Idamycin (Idarubicin) for Leukemia | MyLeukemiaTeam

Connect with others who understand.

sign up Log in
About MyLeukemiaTeam
Powered By

Idamycin is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute myeloid leukemia (AML) in adults. Idamycin is often combined with other drugs such as cytarabine in specific chemotherapy regimens. Idamycin is also known by its drug name, iIdarubicin.

Idamycin is an anticancer drug used in chemotherapy. Idamycin is a member of a drug class called anthracycline antibiotics. Idamycin is also a topoisomerase inhibitor. Idamycin is believed to work by damaging DNA and blocking cell division in several different ways.

How do I take it?
Idamycin is administered as an intravenous infusion during chemotherapy treatment.

Side effects
The FDA-approved label for Idamycin lists common side effects including frequent infections, hair loss, nausea, vomiting, diarrhea, abdominal cramps, mouth sores, and abnormal bleeding.

Rare but serious side effects listed for Idamycin include heart failure, severe damage to skin at injection sites, and fetal harm in pregnant women.

For more details about this treatment, visit:

Idamycin — Pfizer

AML: Chemotherapy and Drug Therapy — Leukemia & Lymphoma Society

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in